No beneficial effects of human growth hormone therapy in normal ovulatory patients with a poor ovarian response to gonadotropins.
We studied the effects of human growth hormone (hGH) in 7 in vitro fertilization (IVF) patients with normal ovulatory menstrual cycles who showed a low response to ovarian stimulation with follicle-stimulating hormone (FSH) and human menopausal gonadotropin (hMG). Human growth hormone therapy had no significant effect on the number of days of gonadotropic stimulation, on the total amount of hMG administered, on the serum estradiol level on the day of human chorionic gonadotropin injection, or on the IVF outcome. Our preliminary results do not encourage the routine use of hGH to improve IVF outcome in normogonadotropic ovulatory patients who respond poorly to the standard FSH/hMG protocol.
Levron
J
J
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel.
Lewit
N
N
Erlik
Y
Y
Itskovitz-Eldor
J
J
D000328:Adult; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D006062:Gonadotropins / Q000494:pharmacology / Q000627:therapeutic use*; D013006:Growth Hormone / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use; D006080:Ovarian Follicle / Q000187:drug effects; D010062:Ovulation Induction / Q000379:methods*; D016896:Treatment Outcome
D006062:Gonadotropins; D004958:Estradiol; D008596:Menotropins; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone